Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

helix pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; sodium citrate dihydrate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

helix pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; sodium citrate dihydrate; povidone; crospovidone - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

washington homeopathic products - helix - to relieve the symptoms of tickling cough. indications: helix   tickling cough if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

washington homeopathic products - helix - to relieve the symptoms of tickling cough. indications:  helix   tickling cough if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

Evropska unija - angleščina - EMA (European Medicines Agency)

bayer ag  - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor-viii deficiency).this preparation does not contain von willebrand factor and is therefore not indicated in von willebrand's disease.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

csl behring llc - antihemophilic factor, human recombinant (unii: p89dr4ny54) (antihemophilic factor, human recombinant - unii:p89dr4ny54) - antihemophilic factor, human recombinant 250 [iu] in 2.5 ml - helixate® fs is a recombinant antihemophilic factor indicated for: helixate fs is not indicated for the treatment of von willebrand disease. helixate fs is contraindicated in patients who have life-threatening hypersensitivity reactions, including anaphylaxis to mouse or hamster protein or other constituents of the product (sucrose, glycine, histidine, sodium, calcium chloride, polysorbate 80, imidazole, tri-n-butyl phosphate, and copper). pregnancy category c animal reproduction studies have not been conducted with helixate fs. it is also not known whether helixate fs can cause fetal harm when administered to a pregnant woman or affect reproductive capacity. helixate fs should be given to a pregnant woman only if clearly needed. there is no information available on the effect of factor viii replacement therapy on labor and delivery. helixate fs should be used only if clinically needed. it is not known whether this drug is excreted into human milk. because many drugs are excreted into human milk, caution sho

Združene države Amerike - angleščina - NLM (National Library of Medicine)

helix spirits llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - in children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

csl behring uk ltd - octocog alfa - powder and solvent for solution for injection - 250unit

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

csl behring uk ltd - octocog alfa - powder and solvent for solution for injection - 500unit

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

csl behring uk ltd - octocog alfa - powder and solvent for solution for injection - 1000unit